Latest filing published 30 Apr 2021 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €230k.
David Robert Hale appears in our data through filings on Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) shares, published by SEDI. In total, 6 filings cover trades dated from 21 September 2017 to 27 April 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 30 April 2021, the filings show an option exercise worth €230k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 5 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations